Publications
408
Citations
19,570
Est. group size
—
Recurring co-author estimate
Active years
44
Publishing since 1983
Brian M. D'Onofrio studies how mental health conditions such as ADHD (attention-deficit/hyperactivity disorder), substance use disorders, and various psychiatric conditions develop and are treated, and how these risks are shared within families. His work relies heavily on large population and family-based datasets (often from Swedish national registers) to examine the real-world effects and safety of psychiatric medications, including their use during pregnancy. A recurring approach is comparing relatives (such as siblings or twins) to better separate genetic and environmental influences on health outcomes.
Publication activity has remained fairly steady across the decade, fluctuating between roughly 13 and 39 papers per year with an average of about 22 over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Current awards run through May 2030 — about 4 years of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.
Examining the Effects of ADHD Medications on Substance-Related Morbidity and Mortality Among Young People
3 earlier awards
- NIH R01DA048042Apr 2019 – Feb 2024 · $397k awarded
Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes
- NIH R01MH102221Jul 2014 – Mar 2019 · $409k awarded
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems
- NIH R01HD061817Jul 2010 – May 2014 · $324k awarded
Quasi-experimental studies of early risk factors for severe psychopathology
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~9 · 3% small-team papers (≤3 authors) · across 106 venues
- Risk of substance-related problems in hypochondriasis
Psychological Medicine · 2026
- Central nervous system acting medication used by young adults with borderline personality disorder in Sweden 2006–2019
Journal of Psychopharmacology · 2026
- Proneness to infections and familial risk of tic disorders
Psychological Medicine · 2026
- Discontinuation and reinitiation of pharmacological treatment for ADHD among individuals with ADHD and substance use disorder
BMJ Mental Health · 2026
- Short- and long-term incidence of obsessive–compulsive disorder after objectively recorded potentially traumatic events
Nature Mental Health · 2026
- Second-Generation Antipsychotics and Real-World Outcomes in Youth With On- and Off-Label Indications
Journal of the American Academy of Child & Adolescent Psychiatry · 2026
- Shared Genetic Factors Between Stress-related Disorders and Cardiovascular Disease
Genomics Proteomics & Bioinformatics · 2026
- ABS1071 MUSCULOSKELETAL MANIFESTATIONS OF ENTEROPATHIC ARTHRITIS VARY IN RELATION TO INFLAMMATORY BOWEL DISEASE BEHAVIOUR, LOCALIZATION, AND EXTENT
Annals of the Rheumatic Diseases · 2025
- In utero exposure to methylphenidate, amphetamines and atomoxetine and offspring neurodevelopmental disorders – a population-based cohort study and meta-analysis
Molecular Psychiatry · 2025
- Pregnancy Outcomes in Women Diagnosed With Attention‐Deficit/Hyperactivity Disorder: A Population‐Based Register Study
Acta Psychiatrica Scandinavica · 2025
- Association between parental psychiatric conditions and offspring psychiatric, behavioral, and psychosocial outcomes: A Swedish population-based children-of-monozygotic twins study
PLoS Medicine · 2025
- Incident benzodiazepine and Z-drug use and subsequent risk of alcohol- and drug-related problems: A nationwide matched cohort study with co-twin comparison
Journal of Psychopharmacology · 2025
- Assessing the association between child maltreatment and chronic pain: a cross-sectional co-twin control study
Pain · 2025
- Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals
The Lancet Psychiatry · 2025
- Sociodemographic and clinical characteristics of 1,234 individuals diagnosed with trichotillomania in the Swedish National Patient Register
Scientific Reports · 2025
- JAMA Psychiatry×17
- Journal of Child Psychology and Psychiatry×15
- Molecular Psychiatry×12
- Psychological Medicine×9
- PLoS Medicine×8
- Paul Lichtenstein
Medicine · Indiana University
- Kelsey K. Wiggs
Medicine · Indiana University
- Elizaveta Bourchtein
Medicine · University of Michigan
- Heather A. Ciesielski
Medicine · Purdue University West Lafayette
- Anne E. Dawson
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile